CGA
IBB icon

Crescent Grove Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.01M Sell
31,672
-730
-2% -$92.4K 0.39% 56
2025
Q1
$4.14M Sell
32,402
-1,944
-6% -$249K 0.43% 49
2024
Q4
$4.54M Sell
34,346
-8,454
-20% -$1.12M 0.45% 48
2024
Q3
$6.23M Sell
42,800
-749
-2% -$109K 0.64% 30
2024
Q2
$5.98M Sell
43,549
-4,161
-9% -$571K 0.65% 31
2024
Q1
$6.55M Sell
47,710
-4,528
-9% -$621K 0.68% 31
2023
Q4
$7.1M Sell
52,238
-5,683
-10% -$772K 0.79% 27
2023
Q3
$7.09M Sell
57,921
-11,804
-17% -$1.45M 0.88% 23
2023
Q2
$8.85M Sell
69,725
-2,878
-4% -$365K 0.95% 23
2023
Q1
$9.38M Sell
72,603
-4,391
-6% -$567K 1.09% 23
2022
Q4
$10.1M Buy
76,994
+3,765
+5% +$494K 1.05% 24
2022
Q3
$8.57M Buy
73,229
+439
+0.6% +$51.3K 0.99% 22
2022
Q2
$8.56M Buy
72,790
+12,032
+20% +$1.42M 0.9% 23
2022
Q1
$7.92M Buy
60,758
+7,128
+13% +$929K 0.78% 23
2021
Q4
$8.19M Buy
53,630
+8,272
+18% +$1.26M 0.77% 23
2021
Q3
$7.33M Buy
45,358
+1,605
+4% +$259K 0.78% 22
2021
Q2
$7.16M Buy
43,753
+1,308
+3% +$214K 0.75% 24
2021
Q1
$6.39M Sell
42,445
-3,238
-7% -$488K 0.75% 27
2020
Q4
$6.92M Buy
45,683
+2,797
+7% +$424K 0.9% 25
2020
Q3
$5.81M Buy
42,886
+1,545
+4% +$209K 1.16% 20
2020
Q2
$5.65M Sell
41,341
-545
-1% -$74.5K 1.19% 18
2020
Q1
$4.51M Sell
41,886
-2,601
-6% -$280K 1% 22
2019
Q4
$5.36M Sell
44,487
-521
-1% -$62.8K 0.93% 23
2019
Q3
$4.48M Buy
45,008
+14
+0% +$1.39K 0.86% 25
2019
Q2
$4.91M Sell
44,994
-2,674
-6% -$292K 0.93% 21
2019
Q1
$5.33M Sell
47,668
-12,239
-20% -$1.37M 1.09% 18
2018
Q4
$5.78M Sell
59,907
-14,267
-19% -$1.38M 1.23% 19
2018
Q3
$9.05M Sell
74,174
-85
-0.1% -$10.4K 1.95% 10
2018
Q2
$8.17M Sell
74,259
-6,323
-8% -$695K 2.03% 10
2018
Q1
$8.6M Buy
80,582
+6,476
+9% +$691K 2.11% 9
2017
Q4
$7.91M Buy
74,106
+53,841
+266% +$5.75M 1.99% 9
2017
Q3
$6.76M Buy
20,265
+1,948
+11% +$650K 1.73% 10
2017
Q2
$5.68M Buy
+18,317
New +$5.68M 1.64% 13